| 000 | 01670 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514195741.0 | ||
| 264 | 0 | _c20040824 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a0300-8916 | ||
| 024 | 7 |
_a10.1177/030089160409000320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiavazzi, Raffaella | |
| 245 | 0 | 0 |
_a45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003. _h[electronic resource] |
| 260 |
_bTumori _c |
||
| 300 |
_a356-62 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiomedical Research |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xcomplications |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMedical Oncology |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNeoplasms _xetiology |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 | _aProteomics |
| 650 | 0 | 4 | _aSocieties, Medical |
| 700 | 1 | _aAglietta, Massimo | |
| 700 | 1 | _aAstolfi, Annalisa | |
| 700 | 1 | _aFalanga, Anna | |
| 700 | 1 | _aFusco, Alfredo | |
| 700 | 1 | _aLabianca, Roberto | |
| 700 | 1 | _aLollini, Pier Luigi | |
| 700 | 1 | _aLombardo, Claudio | |
| 700 | 1 | _aNatali, Pier Giorgio | |
| 700 | 1 | _aPierotti, Marco A | |
| 700 | 1 | _aPresta, Marco | |
| 700 | 1 | _aSantoro, Massimo | |
| 700 | 1 | _aTaraboletti, Giulia | |
| 700 | 1 | _aZupi, Gabriella | |
| 700 | 1 | _aVecchio, Giancarlo | |
| 773 | 0 |
_tTumori _gvol. 90 _gno. 3 _gp. 356-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/030089160409000320 _zAvailable from publisher's website |
| 999 |
_c15014174 _d15014174 |
||